Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression

<p><strong>Background</strong> Despite their revolutionary success in cancer treatment over the last decades, immunotherapies encounter limitations in certain tumor types and patients. The efficacy of immunotherapies depends on tumor antigen-specific CD8 T-cell viability and functi...

Bibliografski detalji
Glavni autori:	Finisguerra, V, Dvorakova, T, Formenti, M, Van Meerbeeck, P, Mignion, L, Gallez, B, Van den Eynde, BJ
Format:	Journal article
Jezik:	English
Izdano:	BMJ Publishing Group 2023

Slični predmeti

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
od: Benoit J Van den Eynde, i dr.
Izdano: (2023-05-01)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
od: Dvorakova, T, i dr.
Izdano: (2024)

Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
od: Zhu, J, i dr.
Izdano: (2017)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
od: Tereza Dvorakova, i dr.
Izdano: (2024-09-01)

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
od: Zhu, J, i dr.
Izdano: (2018)

Immunosuppression mediated by enzymes that degrade tryptophan
od: Van Den Eynde, B
Izdano: (2018)

Preclinical murine tumor models: a structural and functional perspective
od: Guerin, MV, i dr.
Izdano: (2020)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
od: Oliver Kepp, i dr.
Izdano: (2023-12-01)

Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for Radiosensitization?
od: Donatienne d’Hose, i dr.
Izdano: (2022-10-01)

EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells
od: Donatienne d’Hose, i dr.
Izdano: (2022-09-01)

Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
od: Zhe Fu, i dr.
Izdano: (2021-04-01)

Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
od: Shishengnan Song, i dr.
Izdano: (2025-02-01)

Tryptophan 2,3-dioxygenase expression identified in murine decidual stromal cells is not essential for feto-maternal tolerance
od: Hoffmann, D, i dr.
Izdano: (2020)

Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy
od: Joseph M. Steingold, i dr.
Izdano: (2020-09-01)

Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
od: HONG Chenchen, i dr.
Izdano: (2022-11-01)

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
od: Ziyi Bai, i dr.
Izdano: (2022-01-01)

Arid5a: A missing link between EMT and tumoral immune resistance
od: Van den Eynde, BJ
Izdano: (2021)

Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model
od: Heba Mohamed Zaki, i dr.
Izdano: (2024-01-01)

Hypoxia potentiates glioma-mediated immunosuppression.
od: Jun Wei, i dr.
Izdano: (2011-01-01)

The effect of metformin on senescence of T lymphocytes
od: Jia Yang, i dr.
Izdano: (2023-12-01)

Role of the immunosuppressive microenvironment in immunotherapy
od: Garth W. Tormoen, MD, PhD, i dr.
Izdano: (2018-10-01)

The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia
od: Bernard Gallez
Izdano: (2022-07-01)

Learning from the proteasome: how to fine-tune cancer immunotherapy
od: Vigneron, N, i dr.
Izdano: (2017)

Understanding sepsis-induced immunosuppression and organ dysfunctions: from immunosuppression to immunotherapy
od: Dablu Lal Gupta, i dr.
Izdano: (2022-08-01)

Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC
od: Leung, CSK, i dr.
Izdano: (2022)

Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
od: Wioletta Olejarz, i dr.
Izdano: (2020-01-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
od: Xuehua Zhang, i dr.
Izdano: (2022-11-01)

The content of hypoxia-inducible factors and mediators of immunosuppression in the blood in diseases associated with hypoxia
od: S. P. Chumakova, i dr.
Izdano: (2020-10-01)

Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
od: Yunna Chen, i dr.
Izdano: (2024-09-01)

Light‐Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy
od: Xian An, i dr.
Izdano: (2024-09-01)

Preclinical murine tumor models: A structural and functional perspective
od: Marion V Guerin, i dr.
Izdano: (2020-01-01)

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration
od: Lijuan Ding, i dr.
Izdano: (2023-03-01)

Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression
od: Michael F. Coleman, i dr.
Izdano: (2024-06-01)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
od: Delia Hoffmann, i dr.
Izdano: (2020-12-01)

Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
od: Chen, Ivy Xiaoyu, i dr.
Izdano: (2020)

Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer
od: He Huang, i dr.
Izdano: (2022-08-01)

Diffuse Pigment Release in a Patient Undergoing Tumor-Infiltrating Lymphocyte Immunotherapy for Acral Malignant Melanoma
od: Madison Kerley, i dr.
Izdano: (2023-07-01)

Integrating next-generation dendritic Cell vaccines into the current cancer immunotherapy landscape.
od: Garg, A, i dr.
Izdano: (2017)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
od: Maartje W. Rohaan, i dr.
Izdano: (2018-10-01)

Editorial: Immunosuppression mechanisms and immunotherapy strategies in glioblastoma
od: Sihan Xiong, i dr.
Izdano: (2024-04-01)